Omeprazole and Vessel puncture site pain - a phase IV clinical study of FDA data
Summary:
No or too few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or too few reports are found.
What is Omeprazole?
Omeprazole has active ingredients of omeprazole. It is used in gastroesophageal reflux disease. Currently, eHealthMe is studying from 390,211 Omeprazole users.
What is Vessel Puncture Site Pain?
Vessel puncture site pain is found to be associated with 93 drugs and 44 conditions by eHealthMe. Currently, we are studying 125 people who have Vessel puncture site pain.
Do you take Omeprazole and have Vessel puncture site pain?
Check whether Vessel puncture site pain is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Omeprazole side effects by duration, gender and age:
- Omeprazole side effects (390,211 reports)
Vessel puncture site pain treatments and more:
- Vessel puncture site pain (125 reports)
All the drugs that are associated with Vessel puncture site pain:
All the conditions that are associated with Vessel puncture site pain:
How the study uses the data?
The study uses data from the FDA. It is based on omeprazole (the active ingredients of Omeprazole) and Omeprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Krystexxa and Escitalopram Oxalate drug interaction - 5 seconds ago
- Hoarseness Or Changing Voice in Vyvanse, how severe and when it was recovered? - 7 seconds ago
- Vitamin D and Circadian Rhythm Sleep Disorder - 9 seconds ago
- Metoclopramide and Hypertensive Nephropathy - 17 seconds ago
- Pantoprazole and Sciatica Aggravated - 18 seconds ago
- Lyrica and Cardura Xl drug interaction - 26 seconds ago
- Throat Irritation and pfizer biontech covid vaccine - 36 seconds ago
- Tamsulosin and Arterial Occlusive Disease - 37 seconds ago
- Silymarin and Fentanyl drug interaction - 37 seconds ago
- Omnaris and Decreased Activity - 41 seconds ago